世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い
 South Korea Flow Cytometry Market: Analysis and Forecast, 2024-2033
Introduction Flow cytometry has emerged as a transformative technology in South Korea, driven by advancements in research and industrial applications. This versatile technology enables high-thro... もっと見る
SummaryIntroductionFlow cytometry has emerged as a transformative technology in South Korea, driven by advancements in research and industrial applications. This versatile technology enables high-throughput analysis of single cells, offering applications ranging from clinical diagnostics to industrial biotechnology. South Korea’s commitment to innovation and R&D investments has catalyzed the adoption of flow cytometry, with significant contributions from key players like Becton, Dickinson and Company, Danaher Corporation (Beckman Coulter), and Thermo Fisher Scientific Inc. Despite challenges such as high costs and technological complexity, the growth trajectory of flow cytometry in South Korea is promising, supported by government initiatives and increasing healthcare and biotech investments. Market Overview The South Korea flow cytometry market was valued at $82.12 million in 2024 and is projected to reach $244.49 million by 2033, growing at a CAGR of 12.89% during the forecast period (2024-2033). Investments in flow cytometry in the country saw a significant year-on-year increase of 23.23% from $431.3 million in 2020 to $531.5 million in 2021. This upward trend reflects the growing importance of this technology across clinical, research, and industrial domains. Market Segmentation: Segmentation 1: by Product • Instruments • Reagents and Consumables • Imaging Systems and Software Segmentation 2: by Method • Bead-based Flow Cytometry • Cell-based Flow Cytometry Segmentation 3: by Application • Clinical • Research • Industrial Segmentation 4: by End-User • Academic and Research Institutes • Hospitals and Clinical Testing Laboratories • Pharmaceutical and Biotechnology Companies • Industrial Companies • Others Recent Developments: Industrial-Scale Developments • January 2024: SML Meditree partnered with Sengenics to distribute its immune proteomics platform, KREX, in South Korea. • February 2022: IDEXX Laboratories launched the Procyte One analyzer in South Korea, leveraging advanced flow cytometry laser technology. Research-Scale Developments • August 2023: Seoul St. Mary’s Hospital researchers received recognition for their work on MRD monitoring using multi-parametric flow cytometry. • January 2023: Expansion of Eunpyeong St. Mary’s Hospital to enhance its analytical capabilities, including additional flow cytometers. These developments highlight the expanding role of flow cytometry in both research and clinical settings within South Korea. Demand - Drivers and Limitations The following are the demand drivers for South Korea flow cytometry market: • Increasing Healthcare Investments and Biotechnology and Pharmaceutical Manufacturing in South Korea • Increasing Research and Development Expenditure in the Country The market is expected to face some limitations due to the following challenges: • High Cost of Acquisition Conclusion The South Korea flow cytometry market is poised for substantial growth, underpinned by increasing investments in healthcare and biotechnology, advancements in technology, and expanding applications in diagnostics and research. Despite challenges such as high costs and reliance on imports, opportunities in automation, AI integration, and emerging clinical applications position South Korea as a key player in the global flow cytometry landscape. Strategic collaborations and adherence to stringent regulatory standards will further bolster the market’s trajectory over the next decade. How can this report add value to an organization? Product/Innovation Strategy: The South Korea flow cytometry market has been extensively segmented on the basis of various categories, such as product, method, application, and end-user. This can help readers get a clear overview of which segments account for the largest share and which ones are well-positioned to grow in the coming years. Competitive Strategy: A detailed competitive benchmarking of the players operating in the South Korea flow cytometry market has been done to help the reader understand how players stack against each other, presenting a clear market landscape. Additionally, comprehensive competitive strategies such as partnerships, agreements, and collaborations will aid the reader in understanding the untapped revenue pockets in the market. Table of Contents1 Market Overview1.1 Introduction 1.2 Market Footprint 1.2.1 Major Flow Cytometry Systems 1.2.2 Market Penetration of Flow Cytometry 1.2.3 Recent Developments 1.2.4 SWOT Analysis 1.3 Regulatory Compliance 1.4 Technology Landscape 2 Market Dynamics 2.1 Impact Analysis 2.2 Market Drivers 2.2.1 Increasing Healthcare Investments and Biotechnology and Pharmaceutical Manufacturing in South Korea 2.2.2 Increasing Research and Development Expenditure in the Country 2.3 Market Restraints 2.3.1 High Cost of Acquisition 2.4 Market Opportunities 2.4.1 Increasing Use of Automation in Flow Cytometry Laboratories 3 Product Mapping 3.1 Instrument Product Mapping Analysis 3.2 Consumable Product Mapping Analysis 3.3 Imagin System and Software Product Mapping Analysis 4 Competitive Insights 4.1 Product Launches 4.2 Expansion 4.3 Increasing Awareness 4.4 Market Share Analysis (by Company), 2022 and 2023 4.5 Growth-Share Matrix 5 South Korea Flow Cytometry Market, by Product 5.1 Overview 5.2 Instruments 5.2.1 Key Players 5.2.2 Platforms 5.2.3 Replaceable Components and Accessories 5.3 Reagents and Consumables 5.3.1 Key Players 5.3.2 Antibodies 5.3.3 Fluorescent Dye 5.3.4 Beads 5.3.5 Others 5.4 Imaging Systems and Software 6 South Korea Flow Cytometry Market, by Method 6.1 Overview 6.2 Bead-based Flow Cytometry 6.3 Cell-based Flow Cytometry 7 South Korea Flow Cytometry Market, by Application 7.1 Overview 7.2 Clinical Applications 7.2.1 Cancer 7.2.2 Hematology 7.2.3 Autoimmune Diseases 7.2.4 Organ Transplantation 7.2.5 Others 7.3 Research Applications 7.3.1 Drug Discovery 7.3.2 Stem Cell Research 7.3.3 In-Vitro Toxicology Testing 7.3.4 Biomarker Detection 7.3.5 Cell Apoptosis 7.3.6 Cell Cycle Analysis 7.3.7 Cell Viability 7.3.8 Others 7.4 Industrial Applications 7.4.1 Food and Beverages 7.4.2 Water Treatment 7.4.3 Microbiology Testing 7.4.4 Cosmetics and Personal Care Industry 7.4.5 Agriculture and Fermentation Industry 7.4.6 Other Industries 8 South Korea Flow Cytometry Market, by End Users 8.1 Overview 8.2 Academic and Research Institutes 8.3 Hospitals and Clinical Testing Laboratories 8.4 Pharmaceutical and Biotechnology Companies 8.5 Industrial Companies 8.6 Others 9 Company Profiles 9.1 Agilent Technologies, Inc. 9.2 Becton, Dickinson and Company 9.3 Bio-Rad Laboratories, Inc. 9.4 Cytek Biosciences, Inc. 9.5 Danaher Corporation (Beckman Coulter) 9.6 II-VI Incorporated 9.7 Sony Group Corporation (Sony Biotechnology) 9.8 Sysmex Corporation 9.9 Thermo Fisher Scientific Inc. 9.10 Miltenyi Biotec Press Release
According to a premium market intelligence study by BIS Research, the South Korea flow cytometry market is projected to reach $244.49 million by 2033. The study also highlights that the market is set to witness a CAGR of 12.89% during the forecast period 2024-2033.
Flow cytometry has made a significant impact in South Korea. This is through the recent developments in the country which include both research scale and industrial scale initiatives by government and private sectors, such as increasing focus on research in the country. Even though flow cytometry is a complex technology, its usage in Korean research institutions as well as industry is growing significantly. USPs of this report • Market dynamic analysis of the opportunities, trends, and challenges in the market • Detailed market segmentation by product, method, end user, and application • Technology Landscape • Product Mapping • Competitive Insights Key Companies Profiled The key players profiled in the report include Agilent Technologies, Inc. , Becton, Dickinson and Company , Bio-Rad Laboratories, Inc. , Cytek Biosciences, Inc. , Danaher Corporation (Beckman Coulter), II-VI Incorporated , Sony Group Corporation (Sony Biotechnology), Sysmex Corporation, Thermo Fisher Scientific Inc. , and Miltenyi Biotec Key Questions Answered in the Report • What are the major market drivers, challenges, and opportunities in the South Korea flow cytometry market? • What is the estimated market size for the South Korea flow cytometry market? • What are the strategies adopted by the key players in the South Korea flow cytometry market?
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野（医療）の最新刊レポート
BIS Research社の医療分野での最新刊レポート
本レポートと同じKEY WORD（cytometry）の最新刊レポート
よくあるご質問BIS Research社はどのような調査会社ですか?多数のアナリストチームと大規模な業界専門家のネットワークを擁するBISリサーチは、市場に影響を与える革新的な技術に関して、高度なマーケットインテリジェンスを提供しています。特に、新興テクノロジーに関す... もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
